Results 111 to 120 of about 195,243 (312)
Decoding Food Labels: How and Why Labels Influence Consumers' Responses
ABSTRACT Consumers make hundreds of food‐related decisions daily, often relying on labels to guide their choices. While extensive research has examined whether food labels are effective and which label types outperform others, limited work has explained how and why labels influence consumers' responses.
Ana Tereza Delapedra +3 more
wiley +1 more source
How do nature-based solutions contribute to biodiversity in cities?
The multifunctional character of nature-based solutions (NbS) in cities, benefiting both biodiversity and human well-being, is gaining increasing attention.
Meng Li +3 more
doaj +1 more source
Background: In the UK almost 7000 people are diagnosed with leukaemia each year, but despite continuing advances in diagnosis and treatment with new drugs, such as the tyrosine kinase inhibitors, the majority of these patients will eventually die from ...
Christian Ottensmeier +7 more
doaj +1 more source
Other therapy options may relegate omacetaxine to last-line choice for chronic or accelerated phase CML [PDF]
Matt Kalaycio
openalex +1 more source
Using data from the Global Burden of Disease Study 2021, we systematically assessed leukemia prevalence and disability‐adjusted life years (DALYs) across 204 countries and territories from 1990 to 2021, stratified by subtype, demographics, and risk factors.
Yuping Wu +8 more
wiley +1 more source
CRISPR Enabled Precision Oncology: From Gene Editing to Tumor Microenvironment Remodeling
CRISPR technology has progressed from a prokaryotic immune system to a diverse suite of editing platforms, including Cas nucleases, base and prime editors, and RNA‐targeting enzymes. These advances enable precise genomic and epigenomic interventions, high‐throughput functional screening, and immune engineering.
Kailai Li +8 more
wiley +1 more source
Cardiovascular care of patients with chronic myeloid leukemia (CML) on tyrosine kinase inhibitor (TKI) therapy [PDF]
Mary Barber +2 more
openalex +1 more source
Single amino acid–based PROTACs trigger degradation of the oncogenic kinase BCR–ABL in chronic myeloid leukemia (CML) [PDF]
Jianchao Zhang +5 more
openalex +1 more source
After analyzing the burden of leukemia in the elderly aged 60–89 years from 1990 to 2019 using the Global Burden of Disease database, we found that although the burden of chronic myeloid leukemia has decreased over the past 30 years, the burden of other types of leukemia has continued to increase to varying degrees.
Jing Wei, Qijian Feng, Ziyuan Lu
wiley +1 more source

